Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History
Eco R1 Capital, LLC
- $1.27 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
289Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$245 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$243 Million4.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$201 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$191 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$115 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.19B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...